Stephen Lazarus
Internal Medicine
Credentials: · ·
History
Research
American Journal of Respiratory and Critical Care Medicine · 2009 · 1,617 citations
Azithromycin for prevention of exacerbations of COPD
New England Journal of Medicine · 2011 · 930 citations
Clinical Significance of Symptoms in Smokers with Preserved Pulmonary Function
New England Journal of Medicine · 2016 · 576 citations
- SP
50 papers
- EI
49 papers
- RL
43 papers
42 papers
41 papers
40 papers
37 papers
32 papers
Grants
- 2016–2023
Carbohydrate-Based Therapy for Lung Disease
National Heart, Lung, and Blood Institute · P01
Project lead · $1.9M · University of California, San Francisco
- 2009–2018
UCSF AsthmaNet Clinical Center
National Heart, Lung, and Blood Institute · U10
Contact PI · $1.7M · University of California, San Francisco
- 2003–2008
COPD Clinical Research Network
National Heart, Lung, and Blood Institute · U10
Contact PI · $2.2M · University of California, San Francisco
- 1987–1990
Non-Immunologic Contact Urticaria and Mast Cells
National Institute of Arthritis and Musculoskeletal and Skin Diseases · R01
Contact PI · $298.3K · University of California, San Francisco
Clinical trials
- 2020–2022
An Observational Study of Beta-Blocker Use in Patients With COPD and Acute MI
Principal investigator · Completed
University of Minnesota
- 2016–2019
Beta-Blockers for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease
Principal investigator · Terminated · Phase 3
University of Minnesota
- 2010–2014
Simvastatin Therapy for Moderate and Severe COPD
Principal investigator · Terminated · Phase 3
University of Minnesota
- 2006–2010
Principal investigator · Completed
University of Minnesota